Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 200, Issue 6, Pages 704-707Publisher
WILEY
DOI: 10.1111/bjh.18634
Keywords
mass spectrometry; monoclonal gammopathy; multiple myeloma; plasma cell dyscrasia; screening
Categories
Ask authors/readers for more resources
This article discusses the potential benefits and drawbacks of screening for plasma cell dyscrasias, as well as the implications of using mass spectrometry for diagnosing monoclonal gammopathy of undetermined significance in routine practice.
In this perspective, we highlight both the promise and harms of screening for plasma cell dyscrasias, as well as the implications of the use of mass spectrometry for diagnosing monoclonal gammopathy of undetermined significance in routine practice.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
